Prof. Serena Nik-Zainal.

IF 11.7 1区医学 Q1 CELL BIOLOGY

Cell Reports Medicine Pub Date : 2024-09-17 DOI:10.1016/j.xcrm.2024.101739

Serena Nik-Zainal

引用次数: 0

Abstract

Serena Nik-Zainal, MD, PhD, is professor of genomic medicine and bioinformatics and an honorary consultant in clinical genetics at the University of Cambridge. Prof. Nik-Zainal has dedicated her career to studying the physiology of cancer mutagenesis via a combination of computational and experimental work, as well as validation with clinical data. Among the many awards she has earned for her work, she has recently received the 2024 ESMO Award for Translational Research, for the research in the field of mutational signatures and her efforts in translating their use into clinics.

查看原文本刊更多论文

Serena Nik-Zainal 教授。

Serena Nik-Zainal，医学博士，剑桥大学基因组医学和生物信息学教授，临床遗传学名誉顾问。Nik-Zainal 教授的职业生涯致力于通过计算和实验相结合的方式研究癌症诱变生理学，并通过临床数据进行验证。她的工作赢得了许多奖项，其中包括最近获得的 2024 年 ESMO 转化研究奖，以表彰她在突变特征领域的研究以及将突变特征应用于临床的努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell Reports Medicine Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)

CiteScore

15.00

自引率

1.40%

发文量

231

审稿时长

40 days

期刊介绍： Cell Reports Medicine is an esteemed open-access journal by Cell Press that publishes groundbreaking research in translational and clinical biomedical sciences, influencing human health and medicine. Our journal ensures wide visibility and accessibility, reaching scientists and clinicians across various medical disciplines. We publish original research that spans from intriguing human biology concepts to all aspects of clinical work. We encourage submissions that introduce innovative ideas, forging new paths in clinical research and practice. We also welcome studies that provide vital information, enhancing our understanding of current standards of care in diagnosis, treatment, and prognosis. This encompasses translational studies, clinical trials (including long-term follow-ups), genomics, biomarker discovery, and technological advancements that contribute to diagnostics, treatment, and healthcare. Additionally, studies based on vertebrate model organisms are within the scope of the journal, as long as they directly relate to human health and disease.